165 related articles for article (PubMed ID: 31891054)
1. P-MAPA and IL-12 Differentially Regulate Proteins Associated with Ovarian Cancer Progression: A Proteomic Study.
Júnior LAL; Cucielo MS; Domeniconi RF; Dos Santos LD; Silveira HS; da Silva Nunes I; Martinez M; Martinez FE; Fávaro WJ; Chuffa LGA
ACS Omega; 2019 Dec; 4(26):21761-21777. PubMed ID: 31891054
[TBL] [Abstract][Full Text] [Related]
2. P-MAPA and Interleukin-12 Reduce Cell Migration/Invasion and Attenuate the Toll-Like Receptor-Mediated Inflammatory Response in Ovarian Cancer SKOV-3 Cells: A Preliminary Study.
Lupi LA; Delella FK; Cucielo MS; Romagnoli GG; Kaneno R; Nunes IDS; Domeniconi RF; Martinez M; Martinez FE; Fávaro WJ; Chuffa LGA
Molecules; 2019 Dec; 25(1):. PubMed ID: 31861351
[TBL] [Abstract][Full Text] [Related]
3. P-MAPA immunotherapy potentiates the effect of cisplatin on serous ovarian carcinoma through targeting TLR4 signaling.
de Almeida Chuffa LG; de Moura Ferreira G; Lupi LA; da Silva Nunes I; Fávaro WJ
J Ovarian Res; 2018 Jan; 11(1):8. PubMed ID: 29343281
[TBL] [Abstract][Full Text] [Related]
4. P-MAPA activates TLR2 and TLR4 signaling while its combination with IL-12 stimulates CD4+ and CD8+ effector T cells in ovarian cancer.
Silveira HS; Lupi LA; Romagnoli GG; Kaneno R; da Silva Nunes I; Fávaro WJ; de Almeida Chuffa LG
Life Sci; 2020 Aug; 254():117786. PubMed ID: 32433918
[TBL] [Abstract][Full Text] [Related]
5. Alterations in ubiquitin ligase Siah-2 and its corepressor N-CoR after P-MAPA immunotherapy and anti-androgen therapy: new therapeutic opportunities for non-muscle invasive bladder cancer.
Garcia PV; Apolinário LM; Böckelmann PK; da Silva Nunes I; Duran N; Fávaro WJ
Int J Clin Exp Pathol; 2015; 8(5):4427-43. PubMed ID: 26191134
[TBL] [Abstract][Full Text] [Related]
6. Effects of P-MAPA immunomodulator on Toll-like receptor 2, ROS, nitric oxide, MAPKp38 and IKK in PBMC and macrophages from dogs with visceral leishmaniasis.
Melo LM; Perosso J; Almeida BF; Silva KL; Somenzari MA; de Lima VM
Int Immunopharmacol; 2014 Feb; 18(2):373-8. PubMed ID: 24374021
[TBL] [Abstract][Full Text] [Related]
7. Improvement in clinical signs and cellular immunity of dogs with visceral leishmaniasis using the immunomodulator P-MAPA.
Santiago ME; Neto LS; Alexandre EC; Munari DP; Andrade MM; Somenzari MA; Ciarlini PC; de Lima VM
Acta Trop; 2013 Sep; 127(3):174-80. PubMed ID: 23639468
[TBL] [Abstract][Full Text] [Related]
8. Natural killer cell activity, lymphocyte proliferation, and cytokine profile in tumor-bearing mice treated with MAPA, a magnesium aggregated polymer from Aspergillus oryzae.
Justo GZ; Durán N; Queiroz ML
Immunopharmacol Immunotoxicol; 2003 Aug; 25(3):305-19. PubMed ID: 19180795
[TBL] [Abstract][Full Text] [Related]
9. D-Serine exposure resulted in gene expression changes implicated in neurodegenerative disorders and neuronal dysfunction in male Fischer 344 rats.
Davidson ME; Kerepesi LA; Soto A; Chan VT
Arch Toxicol; 2009 Aug; 83(8):747-62. PubMed ID: 19212759
[TBL] [Abstract][Full Text] [Related]
10. Quantitative Proteomic Profiling Reveals That Diverse Metabolic Pathways Are Influenced by Melatonin in an in Vivo Model of Ovarian Carcinoma.
Chuffa LG; Lupi Júnior LA; Seiva FR; Martinez M; Domeniconi RF; Pinheiro PF; Dos Santos LD; Martinez FE
J Proteome Res; 2016 Oct; 15(10):3872-3882. PubMed ID: 27604906
[TBL] [Abstract][Full Text] [Related]
11. Effect of integrin‑linked kinase gene silencing on microRNA expression in ovarian cancer.
Yuan D; Zhao Y; Wang Y; Che J; Tan W; Jin Y; Wang F; Li P; Fu S; Liu Q; Zhu W
Mol Med Rep; 2017 Nov; 16(5):7267-7276. PubMed ID: 28944870
[TBL] [Abstract][Full Text] [Related]
12. WNT5A-ROR2 is induced by inflammatory mediators and is involved in the migration of human ovarian cancer cell line SKOV-3.
Arabzadeh S; Hossein G; Salehi-Dulabi Z; Zarnani AH
Cell Mol Biol Lett; 2016; 21():9. PubMed ID: 28536612
[TBL] [Abstract][Full Text] [Related]
13. P-mapa, a promisor immunomodulator against tumor cells of colonic tissues: An investigation of the action mechanism over the TLR4 signaling pathway.
Socca EAR; Reis SK; Genaro SC; Leite SK; Reis IB; Bockëlmann PK; Durán N; Fávaro WJ
Life Sci; 2020 Feb; 242():117185. PubMed ID: 31862453
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of myelopoiesis in Listeria monocytogenes-infected mice by an aggregated polymer isolated from Aspergillus oryzae.
de Melo A; Justo GZ; de Souza Queiroz ML
Hum Exp Toxicol; 2001 Jan; 20(1):38-45. PubMed ID: 11339624
[TBL] [Abstract][Full Text] [Related]
15. Dual-specificity phosphatase 5 suppresses ovarian cancer progression by inhibiting IL-33 signaling.
Wang L; Hu J; Qiu D; Gao H; Zhao W; Huang Y; Jiang T; Zhou J; Chen Y
Am J Transl Res; 2019; 11(2):844-854. PubMed ID: 30899384
[TBL] [Abstract][Full Text] [Related]
16. Proteins of the Wnt signaling pathway as targets for the regulation of CD133+ cancer stem cells in glioblastoma.
Shevchenko V; Arnotskaya N; Korneyko M; Zaytsev S; Khotimchenko Y; Sharma H; Bryukhovetskiy I
Oncol Rep; 2019 May; 41(5):3080-3088. PubMed ID: 30864699
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-18 enhances breast cancer cell migration via down-regulation of claudin-12 and induction of the p38 MAPK pathway.
Yang Y; Cheon S; Jung MK; Song SB; Kim D; Kim HJ; Park H; Bang SI; Cho D
Biochem Biophys Res Commun; 2015 Apr; 459(3):379-86. PubMed ID: 25727011
[TBL] [Abstract][Full Text] [Related]
18. Quantitative Proteome Analysis of
Sharma KB; Sharma M; Aggarwal S; Yadav AK; Bhatnagar S; Vrati S; Kalia M
mSystems; 2019 Nov; 4(6):. PubMed ID: 31690592
[TBL] [Abstract][Full Text] [Related]
19. IL-6 and IL-8 are involved in JMJD2A-regulated malignancy of ovarian cancer cells.
Zhang H; Wang Z; Wang F; Wang C; Zhang H
Arch Biochem Biophys; 2020 May; 684():108334. PubMed ID: 32173334
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of interleukin-1 (alpha and beta), interleukin-2 secretion and surface expression of interleukin-2 receptor (IL-2R) by a novel cytokine interleukin-1 receptor antagonist (IL-1ra).
Conti P; Panara MR; Porrini AM; Gambi D; Barbacane RC; Reale M; Bongrazio M; Dempsey RA
Scand J Immunol; 1992 Jul; 36(1):27-33. PubMed ID: 1535451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
